These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 18095993

  • 1. Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas.
    Heyl J, Mehregan D.
    J Cutan Pathol; 2008 Jan; 35(1):40-5. PubMed ID: 18095993
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM, Cabral E, Dadras SS, Cassarino DS.
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [Abstract] [Full Text] [Related]

  • 3. Distinction of benign sebaceous proliferations from sebaceous carcinomas by immunohistochemistry.
    Cabral ES, Auerbach A, Killian JK, Barrett TL, Cassarino DS.
    Am J Dermatopathol; 2006 Dec; 28(6):465-71. PubMed ID: 17122489
    [Abstract] [Full Text] [Related]

  • 4. The diagnostic use of low molecular weight keratin expression in sebaceous carcinoma.
    Murata T, Nakashima Y, Takeuchi M, Sueishi K, Inomata H.
    Pathol Res Pract; 1993 Sep; 189(8):888-93. PubMed ID: 7508102
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemistry in ocular carcinomas.
    Sramek B, Lisle A, Loy T.
    J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
    [Abstract] [Full Text] [Related]

  • 6. Cytokeratin 15 expression in neoplasms with sebaceous differentiation.
    Misago N, Narisawa Y.
    J Cutan Pathol; 2006 Sep; 33(9):634-41. PubMed ID: 16965339
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic utility of adipophilin immunostain in periocular carcinomas.
    Milman T, Schear MJ, Eagle RC.
    Ophthalmology; 2014 Apr; 121(4):964-71. PubMed ID: 24290802
    [Abstract] [Full Text] [Related]

  • 8. Dimorphic immunohistochemical staining in ocular sebaceous neoplasms: a useful diagnostic aid.
    Johnson JS, Lee JA, Cotton DW, Lee WR, Parsons MA.
    Eye (Lond); 1999 Apr; 13 ( Pt 1)():104-8. PubMed ID: 10396393
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
    Ansai S, Arase S, Kawana S, Kimura T.
    J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
    [Abstract] [Full Text] [Related]

  • 10. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors.
    Raphael SJ, McKeown-Eyssen G, Asa SL.
    Mod Pathol; 1994 Apr; 7(3):295-300. PubMed ID: 7520169
    [Abstract] [Full Text] [Related]

  • 11. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
    Mittal R, Araujo I, Czanner G, Coupland SE.
    Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical expression of survivin in cutaneous sebaceous lesions.
    Calder KB, Khalil FK, Schlauder S, Cualing HD, Morgan MB.
    Am J Dermatopathol; 2008 Dec; 30(6):545-8. PubMed ID: 19033926
    [Abstract] [Full Text] [Related]

  • 13. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck.
    Serrano MF, El-Mofty SK, Gnepp DR, Lewis JS.
    Hum Pathol; 2008 Apr; 39(4):591-8. PubMed ID: 18284937
    [Abstract] [Full Text] [Related]

  • 14. Sebaceous carcinoma, basal cell carcinoma, trichoadenoma, trichoblastoma, and syringocystadenoma papilliferum arising within a nevus sebaceus.
    Miller CJ, Ioffreda MD, Billingsley EM.
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1546-9. PubMed ID: 15606837
    [Abstract] [Full Text] [Related]

  • 15. Collision sebaceous and basal cell carcinomas of the eyelid.
    Levy J, Cagnano E, Benharroch D, Monos T, Lifshitz T.
    Ann Diagn Pathol; 2006 Jun; 10(3):157-9. PubMed ID: 16730311
    [Abstract] [Full Text] [Related]

  • 16. Expression of oestrogen and progesterone receptors in canine sebaceous gland tumours.
    Ginel PJ, Lucena R, Millán Y, González-Medina S, Guil S, García-Monterde J, de los Monteros AE, de las Mulas JM.
    Vet Dermatol; 2010 Jun; 21(3):297-302. PubMed ID: 20030798
    [Abstract] [Full Text] [Related]

  • 17. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
    Plaza JA, Ortega PF, Bengana C, Stockman DL, Suster S.
    Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
    [Abstract] [Full Text] [Related]

  • 18. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
    Jakobiec FA, Werdich X.
    Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.
    Sinard JH.
    Arch Ophthalmol; 1999 Jun; 117(6):776-83. PubMed ID: 10369589
    [Abstract] [Full Text] [Related]

  • 20. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.
    Asadi-Amoli F, Khoshnevis F, Haeri H, Jahanzad I, Pazira R, Shahsiah R.
    Am J Clin Pathol; 2010 Jul; 134(1):22-6. PubMed ID: 20551262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.